Trial intelligence / Profile preview

Bedaquiline and Pretomanid Combinations in Pulmonary Tuberculosis

NCT01215851Phase 2Completed

Sponsor
TB Alliance
Start
Oct 2010
Primary completion
May 2011
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bedaquiline, pretomanid in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Oct 2010; status: completed.

02

Drugs

bedaquilinepretomanid
03

Conditions

pulmonary tuberculosis (TB)

Beyond the preview

Go deeper on NCT01215851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01215851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call